Preventing dementia by preventing stroke: The Berlin Manifesto DOI
Vladimir Hachinski,

Karl M. Einhäupl,

Detlev Ganten

et al.

Alzheimer s & Dementia, Journal Year: 2019, Volume and Issue: 15(7), P. 961 - 984

Published: July 1, 2019

Abstract The incidence of stroke and dementia are diverging across the world, rising for those in low‐ middle‐income countries falling high‐income countries. This suggests that whatever factors cause these trends potentially modifiable. At population level, neurological disorders as a group account largest proportion disability‐adjusted life years globally (10%). Among disorders, (42%) (10%) dominate. Stroke confer risks each other share some same, largely modifiable, risk protective factors. In principle, 90% strokes 35% dementias have been estimated to be preventable. Because doubles chance developing is more common than dementia, third could prevented by preventing stroke. Developments at pathological, pathophysiological, clinical level also point new directions. Growing understanding brain pathophysiology has unveiled reciprocal interaction cerebrovascular disease neurodegeneration identifying therapeutic targets include protection endothelium, blood‐brain barrier, components neurovascular unit. addition, targeting amyloid angiopathy aspects inflammation genetic manipulation hold testable promise. meantime, accumulating evidence whole populations experiencing improved education, lower vascular factor profiles (e.g., reduced prevalence smoking) disease, including stroke, better cognitive function rates. individual levels, trials demonstrated anticoagulation atrial fibrillation can reduce 48% systolic blood pressure 140 mmHg may brain. Based on considerations, World Organization issued proclamation, endorsed all major international organizations focused global cardiovascular health, calling joint prevention dementia. article summarizes translation into action.

Language: Английский

The blood–brain barrier and blood–tumour barrier in brain tumours and metastases DOI
Costas D. Arvanitis, Gino B. Ferraro, Rakesh K. Jain

et al.

Nature reviews. Cancer, Journal Year: 2019, Volume and Issue: 20(1), P. 26 - 41

Published: Oct. 10, 2019

Language: Английский

Citations

1283

A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity DOI Creative Commons

Hossam Kadry,

Behnam Noorani, Luca Cucullo

et al.

Fluids and Barriers of the CNS, Journal Year: 2020, Volume and Issue: 17(1)

Published: Nov. 18, 2020

Abstract The blood–brain barrier is playing a critical role in controlling the influx and efflux of biological substances essential for brain’s metabolic activity as well neuronal function. Thus, functional structural integrity BBB pivotal to maintain homeostasis brain microenvironment. different cells structures contributing developing this are summarized along with functions that plays at brain–blood interface. We also explained shear stress maintaining integrity. Furthermore, we elaborated on clinical aspects correlate between disruption neurological pathological conditions. Finally, discussed several biomarkers can help assess permeability in-vitro or in-vivo briefly explain their advantages disadvantages.

Language: Английский

Citations

1119

Single-Cell Transcriptome Atlas of Murine Endothelial Cells DOI Creative Commons
Joanna Kalucka, Laura de Rooij,

Jermaine Goveia

et al.

Cell, Journal Year: 2020, Volume and Issue: 180(4), P. 764 - 779.e20

Published: Feb. 1, 2020

Language: Английский

Citations

1009

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease DOI Creative Commons
Tiantian Guo, Denghong Zhang,

Yuzhe Zeng

et al.

Molecular Neurodegeneration, Journal Year: 2020, Volume and Issue: 15(1)

Published: July 16, 2020

Abstract Alzheimer’s disease (AD) is the most common neurodegenerative disorder seen in age-dependent dementia. There currently no effective treatment for AD, which may be attributed part to lack of a clear underlying mechanism. Studies within last few decades provide growing evidence central role amyloid β (Aβ) and tau, as well glial contributions various molecular cellular pathways AD pathogenesis. Herein, we review recent progress with respect Aβ- tau-associated mechanisms, discuss dysfunction emphasis on neuronal receptors that mediate Aβ-induced toxicity. We also other critical factors affect pathogenesis, including genetics, aging, variables related environment, lifestyle habits, describe potential apolipoprotein E (APOE), viral bacterial infection, sleep, microbiota. Although have gained much towards understanding aspects this devastating disorder, greater commitment research mechanism, diagnostics will needed future research.

Language: Английский

Citations

703

The blood–brain barrier: Structure, regulation and drug delivery DOI Creative Commons
Di Wu, Qi Chen, Xiaojie Chen

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: May 25, 2023

Abstract Blood–brain barrier (BBB) is a natural protective membrane that prevents central nervous system (CNS) from toxins and pathogens in blood. However, the presence of BBB complicates pharmacotherapy for CNS disorders as most chemical drugs biopharmaceuticals have been impeded to enter brain. Insufficient drug delivery into brain leads low therapeutic efficacy well aggravated side effects due accumulation other organs tissues. Recent breakthrough materials science nanotechnology provides library advanced with customized structure property serving powerful toolkit targeted delivery. In-depth research field anatomical pathological study on further facilitates development brain-targeted strategies enhanced crossing. In this review, physiological different cells contributing are summarized. Various emerging permeability regulation crossing including passive transcytosis, intranasal administration, ligands conjugation, coating, stimuli-triggered disruption, overcome obstacle highlighted. Versatile systems ranging organic, inorganic, biologics-derived their synthesis procedures unique physio-chemical properties summarized analyzed. This review aims provide an up-to-date comprehensive guideline researchers diverse fields, offering perspectives system.

Language: Английский

Citations

598

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission DOI
Gill Livingston, Jonathan Huntley, Kathy Liu

et al.

The Lancet, Journal Year: 2024, Volume and Issue: 404(10452), P. 572 - 628

Published: July 31, 2024

Language: Английский

Citations

559

Vascular Cognitive Impairment and Dementia DOI Creative Commons
Costantino Iadecola, Marco Duering, Vladimir Hachinski

et al.

Journal of the American College of Cardiology, Journal Year: 2019, Volume and Issue: 73(25), P. 3326 - 3344

Published: June 24, 2019

Language: Английский

Citations

550

A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk DOI Open Access
Andrew C. Yang,

Ryan T. Vest,

Fabian Kern

et al.

Nature, Journal Year: 2022, Volume and Issue: 603(7903), P. 885 - 892

Published: Feb. 14, 2022

Language: Английский

Citations

527

Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression DOI
Thomas T. van Sloten, Sanaz Sedaghat, Mercedes R. Carnethon

et al.

The Lancet Diabetes & Endocrinology, Journal Year: 2020, Volume and Issue: 8(4), P. 325 - 336

Published: March 2, 2020

Language: Английский

Citations

481

The blood-brain barrier: Physiology and strategies for drug delivery DOI
Rucha Pandit, Liyu Chen, Jürgen Götz

et al.

Advanced Drug Delivery Reviews, Journal Year: 2019, Volume and Issue: 165-166, P. 1 - 14

Published: Nov. 29, 2019

Language: Английский

Citations

449